Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) therapeutics, a new class of RNA medicines with the potential to treat a wide range of diseases including cancer, autoimmune, and genetic disorders. Built on research from Prof. Daniel Anderson’s lab at MIT, oRNA is described by the company as the next revolution […]

View post to subscribe to site newsletter.

Baccuico has developed a proprietary bacterial cultivation platform that combines directed evolution, next generation sequencing, and machine learning to access novel compounds from biological ‘dark matter’. The company’s Bacterial Community Cultivation platform (BACCU) directs the evolution of unculturable bacteria, so that the bacteria evolve to become culturable in the lab. Once brought into the laboratory, […]

View post to subscribe to site newsletter.

ExploRNA Therapeutics is a spin-off from the University of Warsaw, developing next generation mRNA technology for applications such as anti-cancer vaccines. ExploRNA Therapeutics was founded by Professor Jacek Jemielity, Head of the Bio Organic Chemistry Laboratory at the Center of New Technologies CeNT at the University of Warsaw. Professor Jemielity’s first generation ‘cap modification’ mRNA […]

View post to subscribe to site newsletter.